Structures of HCMV Trimer reveal the basis for receptor recognition and cell entry

Marc Kschonsak,Lionel Rougé,Christopher P Arthur,Ho Hoangdung,Nidhi Patel,Ingrid Kim,Matthew C Johnson,Edward Kraft,Alexis L Rohou,Avinash Gill,Nadia Martinez-Martin,Jian Payandeh,Claudio Ciferri,Christopher P. Arthur,Matthew C. Johnson,Alexis L. Rohou
DOI: https://doi.org/10.1016/j.cell.2021.01.036
IF: 64.5
2021-03-01
Cell
Abstract:Structures of HCMV Trimer reveal insight into architecture and HCMV neutralizationHCMV Trimer uncovers a molecular switch in gL for incorporation of either gO or ULsReceptor-bound structures reveal a surface on gO for new therapeutic targetingHCMV Trimer-PDGFRα interaction inhibits PDGFRα signalingHuman cytomegalovirus (HCMV) infects the majority of the human population and represents the leading viral cause of congenital birth defects. HCMV utilizes the glycoproteins gHgLgO (Trimer) to bind to platelet-derived growth factor receptor alpha (PDGFRα) and transforming growth factor beta receptor 3 (TGFβR3) to gain entry into multiple cell types. This complex is targeted by potent neutralizing antibodies and represents an important candidate for therapeutics against HCMV. Here, we determine three cryogenic electron microscopy (cryo-EM) structures of the trimer and the details of its interactions with four binding partners: the receptor proteins PDGFRα and TGFβR3 as well as two broadly neutralizing antibodies. Trimer binding to PDGFRα and TGFβR3 is mutually exclusive, suggesting that they function as independent entry receptors. In addition, Trimer-PDGFRα interaction has an inhibitory effect on PDGFRα signaling. Our results provide a framework for understanding HCMV receptor engagement, neutralization, and the development of anti-viral strategies against HCMV.Download : Download high-res image (205KB)Download : Download full-size image
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?